Home/Filings/4/0000950170-24-063612
4//SEC Filing

Jain Deepti 4

Accession 0000950170-24-063612

CIK 0001630627other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:30 PM ET

Size

7.4 KB

Accession

0000950170-24-063612

Insider Transaction Report

Form 4
Period: 2024-05-21
Jain Deepti
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-21+33,26033,260 total
    Exercise: $4.97Exp: 2034-05-21Common Stock (33,260 underlying)
  • Award

    Common Stock

    2024-05-21+15,09146,326 total
Footnotes (3)
  • [F1]Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.
  • [F2]Includes 15,486 restricted stock units.
  • [F3]The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Documents

1 file

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001840203

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:30 PM ET
Size
7.4 KB